We are currently completing 508 compliance on all presentations that will be posted; however, please email us attechwatchinbox@hhs.gov to receive compliant files.
![]() 8:30-8:45
|
Welcome: Robert Kadlec, MD, MTM&H, MSAssistant Secretary for Preparedness and Response |
![]() 8:45-9:10
|
Keynote Speaker: Steven H. Walker, PhDDirector, DARPA |
![]() 9:15-9:35
|
Leadership Perspective: ADM Brett Giroir (PDF - 1.3MB)Assistant Secretary for Health |
![]() 9:40-9:55
|
Partner Perspective: Phil Gomez, PhD (PDF - 1.4MB)CEO, SIGA Technologies, Inc. |
![]() 10:00-10:15
|
Partner Perspective: Gordon Naylor (PDF - 1.5MB)President, Seqirus |
10:15-10:30 | BREAK | ||
![]() 10:30-12:00
|
BARDA Update
|
||
12:00-1:00 | LUNCH |
TIME | Session | Session | Session |
1:00 - 2:00 | CBRN Programs | Lightning Talks (PDF - 2.4MB) | |
2:00 - 2:15 | Break/Networking Lounge | ||
2:15 - 3:15 | CBRN Programs | Establishing a Whole of Government Approach to ADM (PDF - 1.2MB) | |
3:15 - 3:30 | Break/Networking Lounge | ||
3:30 - 4:30 | Influenza and Emerging Infectious Disease Programs | New Approaches to Combating Opioids | Project BioShield & the Strategic National Stockpile |
![]() 8:45
|
Welcome Back: Rick Bright, PhD (PDF - 0.2MB)BARDA Director
|
![]() 9:00-9:30
|
Keynote Speaker: Martine Rothblatt, PhD, JD (PDF - 5.5MB)CEO, United Therapeutics
|
![]() 9:35-10:05
|
Conversation with Robert Kadlec, MD, MTM&H, MS (PDF - 0.1MB)Assistant Secretary for Preparedness and Response Moderator: Steve Brozak, DMH, MBA, CEO, WBB Securities
|
![]() 10:05-10:25
|
BREAK - Meet & Greet with BARDA Director |
![]() 10:25-11:25
|
Venture Capital Perspectives: Panel Discussion (PDF - 0.5MB)Patrick Heron, Managing General Partner, Frazier Healthcare Partners Andrew Levin, MD, PhD, Managing Director, RA Capital Management Ankit Mahadevia, MD, President & CEO, Spero Therapeutics Moderator: Jay Lichter, PhD, Avalon Ventures |
![]() 11:30-12:00
|
Featured Speaker: Melinda RichterGlobal Head, Johnson & Johnson Innovation, JLABS |
12:00-1:00
|
LUNCH |
TIME | Session |
Session |
Session |
1:00-2:00 | DRIVe | DoD/Collaborating on MCM Priorities | Partnering with BARDA: TechWatch to BAA |
2:00-2:15 | Break/Networking Lounge | ||
2:15-3:15 | Perspectives in Pandemic Influenza Preparedness | Developing Nonclinical Models with Partners | BARDA Public-Private Partnership Case Studies
|
3:15-3:30 | Break/Networking Lounge | ||
3:30-4:30 | Emergency Use Authorizations for MCMs in an Emergency | FDA/Regulatory Considerations for MCM Development | Repurposing for Chemical Medical Countermeasures |